Clinical Trial Update: Immunogenicity of SA 14-14-2 JE Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the immunogenicity of the SA-14-14-2 Japanese encephalitis vaccine in healthy infants has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• SA 14-14-2 Japanese Encephalitis Vaccine (Japanese encephalitis vaccine SA-14-14-2)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Healthy Infants | Phase 4 | Status: COMPLETED